Ming-xiang Zhang

Selected Cytokines Serve as Potential Biomarkers for Predicting Liver Inflammation and Fibrosis in Chronic Hepatitis B Patients With Normal to Mildly Elevated Aminotransferases

J. Shang, Jun Cheng, Guiqiang Wang, 2015, Medicine.

Entecavir combining Chinese herbal medicine for HBeAg-positive chronic hepatitis B patients: a randomized, controlled trial

Liyun He, Y. Ye, X. Chi, 2020, Hepatology International.

Adefovir Dipivoxil plus Chinese Medicine in HBeAg-Positive Chronic Hepatitis B Patients: A Randomized Controlled 48-Week Trial

X. Chi, Guo-liang Zhang, Hong-Zhi Yang, 2020, Chinese Journal of Integrative Medicine.

Chinese Herbal Medicine Combined with Entecavir to Reduce the Off-therapy Recurrence Riks in HBeAg-positive Chronic Hepatitis B Patients: a Multi-center, Double-blind, Randomized Controlled Trial in China

Y. Ye, Guang Chen, W. Lu, 2019 .

3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China

Fu-Sheng Wang, Q. Ning, Hong Tang, 2021, Journal of clinical and translational hepatology.

Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study

J. Shang, J. Jia, H. Ding, 2018, Expert opinion on biological therapy.

Antibody to Hepatitis B Core Antigen Levels in the Natural History of Chronic Hepatitis B

N. Xia, Yan Wang, Jun Li, 2014, Medicine.